The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama, Birmingham
Birmingham, Alabama, United States
- Children'S Hospital of Los Angeles
Los Angeles, California, United States
- Dana-Farber/harvard Cancer Center
Boston, Massachusetts, United States
- St. Jude Children'S Research Hospital
Memphis, Tennessee, United States
- Seattle Children'S Hospital Cancer and Blood Disorders Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Apr 2019
- Primary completion
- 31 Mar 2023
- Completion
- 31 Mar 2024
- Last update posted
- 26 Oct 2024
- Registered enrollment
- 143
- Registry id
- NCT03640325
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.